JP2023528826A5 - - Google Patents
Info
- Publication number
- JP2023528826A5 JP2023528826A5 JP2022573673A JP2022573673A JP2023528826A5 JP 2023528826 A5 JP2023528826 A5 JP 2023528826A5 JP 2022573673 A JP2022573673 A JP 2022573673A JP 2022573673 A JP2022573673 A JP 2022573673A JP 2023528826 A5 JP2023528826 A5 JP 2023528826A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variable region
- amino acid
- acid sequence
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20177354 | 2020-05-29 | ||
| EP20177354.6 | 2020-05-29 | ||
| EP20182325.9 | 2020-06-25 | ||
| EP20182325 | 2020-06-25 | ||
| EP20213562 | 2020-12-11 | ||
| EP20213562.0 | 2020-12-11 | ||
| PCT/EP2021/064326 WO2021239935A1 (en) | 2020-05-29 | 2021-05-28 | Neutralizing antibodies against sars-related coronavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528826A JP2023528826A (ja) | 2023-07-06 |
| JP2023528826A5 true JP2023528826A5 (enExample) | 2024-06-05 |
Family
ID=76250344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573673A Pending JP2023528826A (ja) | 2020-05-29 | 2021-05-28 | Ｓａｒｓ関連コロナウイルスに対する中和抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210371503A1 (enExample) |
| EP (1) | EP4157455A1 (enExample) |
| JP (1) | JP2023528826A (enExample) |
| CA (1) | CA3180556A1 (enExample) |
| TW (1) | TW202210504A (enExample) |
| WO (1) | WO2021239935A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250107297A (ko) | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
| BR112022024662A2 (pt) | 2020-06-03 | 2023-04-04 | Regeneron Pharma | Métodos para tratamento ou prevenção de infecções por sars-cov-2 e covid-19 com anticorpos de glicoproteína spike anti-sars-cov-2 |
| US20240383968A1 (en) * | 2020-12-11 | 2024-11-21 | Boehringer Ingelheim International Gmbh | Formulation for multi-purpose application |
| AU2022221297A1 (en) * | 2021-02-09 | 2023-08-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antibodies targeting the spike protein of coronaviruses |
| WO2022263638A1 (en) * | 2021-06-17 | 2022-12-22 | Centre Hospitalier Universitaire Vaudois (C.H.U.V.) | Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection |
| US12496470B2 (en) * | 2021-07-14 | 2025-12-16 | Regeneron Pharmaceuticals, Inc. | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments |
| WO2023150307A2 (en) * | 2022-02-03 | 2023-08-10 | Abpro Corporation | Compositions and methods against a virus |
| CN118388640A (zh) * | 2022-09-30 | 2024-07-26 | 郴州市第一人民医院 | 一种全人源抗新型冠状病毒SARS-CoV-2的广谱抗体及其应用 |
| WO2025194069A1 (en) * | 2024-03-15 | 2025-09-18 | Atreca, Inc. | Anti-csp antibody variants |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| CA2109528A1 (en) | 1991-05-01 | 1992-11-02 | Gregory A. Prince | A method for treating infectious respiratory diseases |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| ATE508733T1 (de) | 1996-03-04 | 2011-05-15 | Penn State Res Found | Materialien und verfahren zur steigerung der zellulären internalisierung |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| CA2277801C (en) | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| EP0979102A4 (en) | 1997-04-30 | 2005-11-23 | Enzon Inc | DETAILED POLYPEPTIDE MODIFIED BY POLYALKYLENE OXIDE |
| WO1999066903A2 (en) | 1998-06-24 | 1999-12-29 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| WO2005040219A1 (en) | 2003-10-28 | 2005-05-06 | Novo Nordisk A/S | Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| AU2016356780A1 (en) | 2015-11-19 | 2018-06-28 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof |
-
2021
- 2021-05-28 JP JP2022573673A patent/JP2023528826A/ja active Pending
- 2021-05-28 US US17/333,795 patent/US20210371503A1/en active Pending
- 2021-05-28 CA CA3180556A patent/CA3180556A1/en active Pending
- 2021-05-28 WO PCT/EP2021/064326 patent/WO2021239935A1/en not_active Ceased
- 2021-05-28 EP EP21729503.9A patent/EP4157455A1/en active Pending
- 2021-05-28 TW TW110119505A patent/TW202210504A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528826A5 (enExample) | ||
| Weltzin et al. | Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice | |
| US7504107B2 (en) | Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response | |
| JP2023517236A5 (enExample) | ||
| JP2016512554A5 (enExample) | ||
| JP2020523004A5 (enExample) | ||
| JP2023538369A5 (enExample) | ||
| CN1132516A (zh) | 抗呼吸道合胞体病毒的单克隆IgA抗体 | |
| JP7145862B2 (ja) | 抗ＨＳＶ ｇＢモノクローナル抗体又はその抗原結合断片 | |
| JPH06501928A (ja) | ウイルス性呼吸器系疾患の予防または治療のためのエーロゾル | |
| Pan et al. | Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus | |
| CN120282795A (zh) | Omicron冠状病毒疫苗构建体及其制备和使用方法 | |
| JP2021511043A5 (enExample) | ||
| Lamarre et al. | Protection from lethal coronavirus infection by immunoglobulin fragments. | |
| CA3179213A1 (en) | Mers-cov vaccine | |
| CN1437482A (zh) | 用于治疗变态反应的重组的或纯化的多克隆抗体 | |
| JP2010504759A (ja) | ライノウイルスの新規中和性免疫原（ｎｉｍｉｖ）およびワクチン応用のためのその利用 | |
| JP7145863B2 (ja) | 改変型ＨＳＶ ｇＢタンパク質及びこれを含むＨＳＶワクチン | |
| CN113329767A (zh) | 肠道病毒对vero细胞的适应及其疫苗制剂 | |
| Zhu et al. | A broad and potent IgM antibody against tetra-EV-As induced by EVA71 and CVA16 co-immunization | |
| US20150165009A1 (en) | Tlr5 ligands, therapeutic methods, and compositions related thereto | |
| CN111840532A (zh) | 预防病毒性传染病的活疫苗 | |
| JP2022513438A5 (enExample) | ||
| JP2022531205A5 (enExample) | ||
| Bahadir et al. | Monoclonal Antibodies for Pediatric Viral Disease Prevention and Treatment |